Morgan Stanley
SGRX

Morgan Stanley’s SANGRIX INC. Class A Ordinary Shares SGRX Stock Holding History

Morgan Stanley’s Portfolio SGRX Stock Details SGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed -$9K – 7982
2021
Q3 		$9K Sell
1
-2
-67% -$22.2K ﹤0.01% 7360
2021
Q2 		$45K Buy
+3
New +$31.6K ﹤0.01% 6709

Other funds holding SGRX

VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley's SGRX Position: Q4 2021 in Review

Morgan Stanley sold out of SANGRIX INC. Class A Ordinary Shares (SGRX) in Q4 2021, closing a stake of 1 share — an estimated $9K sold.

Morgan Stanley first reported a position in SGRX in Q2 2021 and held it in 2 quarters. The position peaked at $45K in Q2 2021. 7 funds tracked by Wall St. Rank hold SGRX as of Q4 2021.

  • Morgan Stanley reported no remaining SANGRIX INC. Class A Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Morgan Stanley sold 1 SANGRIX INC. Class A Ordinary Shares share in Q4 2021, an estimated $9K.
  • Morgan Stanley first reported a position in SANGRIX INC. Class A Ordinary Shares in Q2 2021 and held it in 2 quarters.
  • Morgan Stanley's SANGRIX INC. Class A Ordinary Shares position peaked at $45K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held SANGRIX INC. Class A Ordinary Shares as of Q4 2021.

Based on Morgan Stanley's 13F filing for Q4 2021, filed 14 Feb 2022.